Skip to Content
MilliporeSigma
All Photos(1)

Key Documents

T9324

Sigma-Aldrich

TAS-301

≥95% (HPLC), solid

Synonym(s):

3-Bis-(4-methoxphenyl)methylene-2-indolinone

Sign Into View Organizational & Contract Pricing


About This Item

Empirical Formula (Hill Notation):
C23H19NO3
CAS Number:
Molecular Weight:
357.40
MDL number:
UNSPSC Code:
12352202
PubChem Substance ID:

assay

≥95% (HPLC)

form

solid

solubility

DMSO: 40 mg/mL

SMILES string

COc1ccc(cc1)\C(c2ccc(OC)cc2)=C3\C(=O)Nc4ccccc34

InChI

1S/C23H19NO3/c1-26-17-11-7-15(8-12-17)21(16-9-13-18(27-2)14-10-16)22-19-5-3-4-6-20(19)24-23(22)25/h3-14H,1-2H3,(H,24,25)

InChI key

KUEYYIJXBRWZIB-UHFFFAOYSA-N

Biochem/physiol Actions

Inhibitor of migration and proliferation in vascular smooth muscle cells; inhibitor of restenosis.
TAS-301 is known to block intimal thickening post balloon injury in rat carotid arteries[1]. It inhibits intimal thickening by blocking Ca2+/calmodulin-dependent protein kinase II (CaM kinase II) and cytoskeletal depolymerization[2]. Moreover, TAS 301 can also inhibit receptor-regulated influx of calcium in rat vascular smooth muscle cells (VSMCs)[3].

Preparation Note

TAS-301 is soluble in DMSO at 40 mg/ml.

Storage Class

11 - Combustible Solids

wgk_germany

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

Eyeshields, Gloves, type N95 (US)


Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

E Sasaki et al.
Pharmacology, 63(1), 17-27 (2001-06-16)
We previously demonstrated that a recently synthesized drug, TAS-301 [3-bis(4-methoxyphenyl)methylene-2-indolinone], inhibited neointimal thickening after single-balloon injury to the rat common carotid artery by inhibiting both the migration and proliferation processes of vascular smooth muscle cells (VSMCs). The purpose of this
E Sasaki et al.
Japanese journal of pharmacology, 84(3), 252-258 (2001-01-04)
The purpose of this study was to determine the effect of a recently synthesized drug, TAS-301 [3-bis(4-methoxyphenyl)methylene-2-indolinone], on vascular smooth muscle cell (VSMC) proliferation and the intracellular signal transduction pathways involved in VSMC proliferation. In an in vitro assay, TAS-301
Y Muranaka et al.
The Journal of pharmacology and experimental therapeutics, 285(3), 1280-1286 (1998-06-17)
The purpose of this study was to determine the efficacy and the possible mechanism of action of a recently synthesized drug, TAS-301 [3-bis (4-methoxyphenyl)methylene-2-indolinone], on intimal formation in comparison with those of tranilast, the clinical efficacy of which was reported

Questions

Reviews

No rating value

Active Filters

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service